Archigen Biotech Limited is a joint venture formed by AstraZeneca and Samsung BioLogics for the research, clinical development, manufacturing,
and global commercialization of biological pharmaceuticals.
We combine a unique range of knowledge, skills and experience with a passion for following the science.
Here are some examples of our key capabilities.
At Archigen, the patient is the highest priority
Our focus is to develop therapeutics that truly improve the lives of patients.
We use our manufacturing process development, analytical characterization, as well as clinical and regulatory competencies to enable increased patient access to high quality biopharmaceutical products.
Archigen Biotech continuously seeks dynamic leaders
Imagine a career with a company that thinks of patients first and is passionate about its employees.
Join Archigen Biotech
as it becomes a modern leader
in biopharmaceutical drug development.
Archigen Biotech Limited. 1 Francis Crick Avenue Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
16F Kamco Tower, 262 Gangnam-daero Gangnam-gu, Seoul 06265, Korea